← Back to catalogue

DIABETES CNTL, Bi-L

FDA UDI

Class I (US FDA UDI)

by Cliniqa Corporation

Identity

Trade Name
DIABETES CNTL, Bi-L FDA UDI
Generic Name
Glucose IVD, control FDA UDI
Device Name
DIABETES CONTROL BI-LEVEL FDA UDI
Model / Reference
91815 FDA UDI
Description
DIABETES CONTROL BI-LEVEL FDA UDI

Identifiers

Primary DI / UDI-DI
00817238010387 FDA UDI
510(k) Number
K060570 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
Glucose IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glucose IVD, control

DIABETES CNTL, Bi-L by Cliniqa Corporation — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glucose IVD, control.

Cleared under the same submission

K060570 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Cliniqa Corporation

Sources (1)

  • FDA UDI 765f2e95-37b3-4bc5-906a-7ee53ce455de 34 fields · synced May 30, 2026